Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Long-Term Debt Repayments (2016 - 2023)

Angiodynamics (ANGO) has disclosed Long-Term Debt Repayments for 13 consecutive years, with $50.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Long-Term Debt Repayments rose 11.11% year-over-year to $50.0 million, compared with a TTM value of $50.0 million through May 2024, up 11.11%, and an annual FY2024 reading of $50.0 million, up 11.11% over the prior year.
  • Long-Term Debt Repayments was $50.0 million for Q3 2023 at Angiodynamics, up from $45.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $132.5 million in Q3 2019 and bottomed at $1.2 million in Q2 2019.
  • Average Long-Term Debt Repayments over 4 years is $41.5 million, with a median of $27.5 million recorded in 2021.
  • Peak annual rise in Long-Term Debt Repayments hit 10500.0% in 2019, while the deepest fall reached 0.0% in 2019.
  • Year by year, Long-Term Debt Repayments stood at $132.5 million in 2019, then plummeted by 92.45% to $10.0 million in 2021, then skyrocketed by 350.0% to $45.0 million in 2022, then increased by 11.11% to $50.0 million in 2023.
  • Business Quant data shows Long-Term Debt Repayments for ANGO at $50.0 million in Q3 2023, $45.0 million in Q3 2022, and $10.0 million in Q2 2021.